Close Menu

NEW YORK (GenomeWeb) – Vela Diagnostics has received approval from the Singapore Health Sciences Authority for in vitro diagnostic use of its Sentosa SQ HIV Genotyping Assay.

The next generation sequencing-based panel also attained CE-IVD status and approval from the Therapeutic Goods Administration in Australia earlier this year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.